Related Experiment Videos
[Uptake of monostearin solid lipid nanoparticles by A549 cells]
Jian-Chao Ding1, Fu-Qiang Hu, Hong Yuan
1College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310031, China.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|February 9, 2005
Summary
PEG2000 modification of monostearin solid lipid nanoparticles (MSLN) enhanced cellular uptake in A549 cells while reducing phagocytosis by J774A1 macrophages. This targeted delivery approach shows promise for specific cell interactions.
Area of Science:
- Nanotechnology
- Materials Science
- Cell Biology
Background:
- Solid lipid nanoparticles (SLNs) are a promising drug delivery system.
- Monostearin solid lipid nanoparticles (MSLN) offer potential for enhanced bioavailability.
- Surface modification of nanoparticles influences cellular interactions and targeting.
Purpose of the Study:
- To evaluate the cellular uptake of MSLN in A549 and J774A1 cell lines.
- To investigate the effect of PEG2000 modification on MSLN cellular uptake.
- To assess the potential of PEGylated MSLN for targeted delivery.
Main Methods:
- MSLN were prepared using a solvent diffusion method.
- Particle size, zeta potential, and cytotoxicity were analyzed.
- Cellular uptake was quantified spectrofluorimetrically using Rhodamine B-labeled MSLN.
Main Results:
- MSLN exhibited low cytotoxicity in A549 cells.
- Cellular uptake of MSLN showed a rapid, concentration-dependent internalization.
- PEG2000 modification significantly increased MSLN uptake in A549 cells but decreased it in J774A1 cells.
Conclusions:
- PEG2000-modified MSLN demonstrate enhanced cellular uptake in alveolar epithelial cells (A549).
- PEG2000 modification reduces phagocytosis by macrophages (J774A1), suggesting potential for immune evasion.
- These findings highlight the potential of PEGylated MSLN for targeted delivery and improved therapeutic efficacy.